Cosmos Health (COSM) said Monday it entered into a distribution agreement with Virax Biolabs (VRAX) to distribute Virax-branded Avian Influenza Virus Real-Time PCR Kits in major European and Gulf Cooperation Council markets.
Financial details weren't disclosed.
Cosmos Health secures exclusive distribution rights for the kits in Greece and Cyprus and non-exclusive rights in European markets, including France, Portugal, Spain, The Netherlands, Belgium, Sweden, Finland, Denmark, Norway, Germany, Switzerland, and Austria.
Cosmos Health said the non-exclusive rights also cover GCC countries Oman and Bahrain.
The agreement allows Cosmos Health to import, sell, and distribute ViraxClear-branded kits in the specified territories, with Virax Biolabs handling regulatory compliance and providing necessary documentation for product registration and approval.
Shares of Cosmos Health were down more than 6% in recent Monday trading, while Virax's were up 2.1%.
Price: 0.58, Change: -0.04, Percent Change: -6.15
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。